PanoramicaGraficoNotizieSchermataTrader

ING Knock-Out VLK/  DE000NG8NPR4  /

Frankfurt Zertifikate
13/11/2024  19:29:44 Var.0.000 Denaro08:50:17 Lettera08:50:17 Sottostante Prezzo di esercizio Expiration date Tipo di opzione
2.110EUR 0.00% -
Quantità in denaro: -		 -
Quantità in lettera: -		 Van Lanschot Kempen ... 22.2059 EUR 31/12/2078 Call
GlobeNewswire 26/06 Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary share...
GlobeNewswire 25/06 Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900...
GlobeNewswire 25/06 Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 90...
GlobeNewswire 30/05 Merus Announces Pricing of Upsized Public Offering of Common Shares
GlobeNewswire 28/05 Merus N.V. Announces Proposed Public Offering of Common Shares
GlobeNewswire 05/04 ORYZON to Provide Corporate Progress Updates at Several Events in April
GlobeNewswire 04/04 Oculis to Participate at Upcoming April Investor Conferences
GlobeNewswire 03/04 Pharming Group to participate in April investor conferences
GlobeNewswire 18/03 Transgene Announces Upcoming Investor Meetings
GlobeNewswire 04/03 Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences
GlobeNewswire 29/02 MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and...
GlobeNewswire 08/02 Autolus Announces Pricing of Underwritten Offering
GlobeNewswire 31/01 Galapagos completes transaction to transfer Jyseleca® business to Alfasigma
GlobeNewswire 22/12/2023 Zealand Pharma enters into EUR 90 million finance agreement with the European Investment Bank
GlobeNewswire 10/10/2023 Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
GlobeNewswire 09/02/2021 SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 22.5 MILLION IN AN EQUITY PLACEMENT
GlobeNewswire 09/02/2021 SEQUANA MEDICAL LAUNCHES EQUITY PLACEMENT
GlobeNewswire 07/07/2020 Mid-Stabilisation Period Announcement
GlobeNewswire 26/06/2020 Hyloris Pharmaceuticals Raises approximately EUR 61.81 million in Successful Initial Public Offering
GlobeNewswire 24/06/2020 Hyloris Pharmaceuticals Announces Narrowing of Price Range of its Initial Public Offering
GlobeNewswire 19/06/2020 Hyloris Pharmaceuticals Announces Coverage of the Maximum Offering Size, including Increase Option a...
GlobeNewswire 18/06/2020 Hyloris Pharmaceuticals Announces the Coverage of the Base Offering Throughout the Price Range of it...
GlobeNewswire 17/06/2020 Hyloris Pharmaceuticals launches its Initial Public Offering on Euronext Brussels
GlobeNewswire 03/06/2020 Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussel...
GlobeNewswire 22/01/2020 Sequana Medical Successfully Raises Eur 19.0 Million in an Equity Placement